Skip to main content

HORIBA, Ltd. (HRIBF)

New York Stock Exchange Technology Hardware, Equipment & PartsView data quality →
66.4Fair

ValueMarkers Composite Index

Top 96%#1,860 of 44,722
Overvalued

38% above intrinsic value ($1)

UndervaluedFair ValueOvervalued
Piotroski
6/9
Neutral
Beneish
-2.81
Low Risk
Altman
2.26
Grey Zone
DCF Value
$1
Overvalued
ROIC
9.0%
Adequate
P/E
23.9
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

HORIBA, Ltd. (HRIBF) — VMCI valuation read

The headline on HORIBA, Ltd. (HRIBF) is a 66/100 VMCI score, set against a Technology sector median of 50. That 16-point above-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value tailwind is in the data.

HRIBF insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** HRIBF trades at 23.0x earnings, 28% above the Technology median of 18.0x sets the value side. ROIC of 19.0% sits 9.0pp above the Technology median (10.0%) sets the quality side. Net debt to EBITDA of 2.7x is the rate-sensitivity line to watch sets the risk side, the three lines a value buyer reads first on HRIBF.

HRIBF rose 1.6% over the trailing 7 days, with a -5.2% read on a 30-day basis.

HORIBA, Ltd. manufactures and sells instruments and systems worldwide. It operates in five segments: Automotive, Process & Environmental, Medical-Diagnostic, Semiconductors, and Scientific. The Automotive segment offers automotive emission analyzers, onboard emission measurement systems, driveline test systems, engine test and fuel cell test systems, and battery test systems; test systems for engines, chassis, powertrains, brakes, and catalysts, as well as water electrolysis cell/stack assessment equipment; and vehicle development engineering and testing engineering services, as well as leases and manages research and development facilities. The Process & Environmental segment provides stack gas analyzers, industrial water quality analyzers, water quality analysis and examination systems, air pollution analyzers, environmental radiation meters, and process measurement equipment. The Medical-Diagnostic segment offers hematology and CRP, immunology, clinical chemistry, and blood glucose analyzers, as well as coagulation/hemostasis analyzers. The Semiconductor Instruments & Systems segment provides mass flow controllers, chemical concentration monitors, reticle/mask particle detection systems, residual gas analyzers, and vaporizers. The Scientific segment offers Raman spectrometers, pH meters, particle-size distribution analyzers, X-Ray fluorescence analyzers, elemental analyzers, fluorescence spectroscopy/fluorescence lifetime spectroscopy, optical components, spectrometers and detectors, and gratings. The company's products are used in arts, entertainment, and recreation; education, research and development, and government institution; food and beverage; energy and environment; health care; industrials; information technology; water; materials; mobility and transport; and waste management applications. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan.

CEO: Atsushi Horiba8,955 employeesJPwww.horiba.com/int

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.